ARRETINI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 528
EU - Europa 253
AS - Asia 78
Totale 859
Nazione #
US - Stati Uniti d'America 524
IT - Italia 67
IE - Irlanda 62
SE - Svezia 51
PL - Polonia 43
HK - Hong Kong 26
CN - Cina 19
JO - Giordania 17
SG - Singapore 11
CH - Svizzera 6
ES - Italia 6
GB - Regno Unito 6
RU - Federazione Russa 6
CA - Canada 4
VN - Vietnam 3
BE - Belgio 2
KR - Corea 2
FI - Finlandia 1
FR - Francia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 859
Città #
Fairfield 101
Dublin 62
Seattle 41
Warsaw 40
Ashburn 37
Chandler 36
Houston 35
Woodbridge 35
Cambridge 31
Wilmington 29
Lawrence 25
Altamura 24
Ann Arbor 22
Florence 18
Hong Kong 16
Princeton 15
Boston 13
Beijing 9
Buffalo 9
Shanghai 8
Barcelona 6
Bern 6
Singapore 6
Boardman 4
Medford 4
New York 4
Andover 3
Milan 3
Moscow 3
San Diego 3
Brussels 2
Chiswick 2
Dong Ket 2
Kent 2
Montepulciano Stazione 2
Nanjing 2
Norwalk 2
Prato 2
Salerno 2
Seoul 2
Siena 2
St. Catharines 2
Toronto 2
Trieste 2
Valeggio sul Mincio 2
Bruino 1
Brusciano 1
Duncan 1
Falls Church 1
Genova 1
Hanoi 1
Hillsboro 1
Islington 1
London 1
Mem Martins 1
Naples 1
Totale 689
Nome #
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 109
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 108
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 88
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy 76
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 74
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology 71
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 69
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 51
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 46
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry 43
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 41
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 38
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 33
Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes 30
Totale 877
Categoria #
all - tutte 3.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 3 2 0 7 13 20 38 31 29 18 21 7
2020/2021160 15 14 9 23 3 4 2 12 11 53 10 4
2021/202295 4 6 5 4 3 3 2 8 12 3 18 27
2022/2023289 23 78 20 1 10 43 37 18 35 2 13 9
2023/2024103 1 10 16 8 8 14 7 21 5 3 6 4
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 877